MAXHEALTHNSEMax Healthcare Institute LimitedLowNeutral
Announced Tue, 17 Mar · 09:54 IST

Max Healthcare Institute Limited has informed the Exchange regarding grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022

Management Changes View source PDF

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹967.00
prior close
₹975.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.2+0.4+0.5+1.3-1.2-0.5-1.4-0.1+1.0-1.0+4.2+9.5+6.5
Up moveDown movePending
AI summary

Max Healthcare Institute Limited has granted 50,000 stock options to an eligible employee under its Employee Stock Option Scheme 2022 (MHIL ESOP 2022). The grant was approved by the Nomination and Remuneration Committee on March 17, 2026. Each option is convertible into one equity share of ₹10 face value at an exercise price of ₹900. Vesting will happen between 1 and 5 years from the grant date, subject to pre-vesting conditions, and employees will have 3 years from each vesting date to exercise the options. The scheme is compliant with SEBI's Share Based Employee Benefits and Sweat Equity Regulations, 2021.

Likely market impact

This is a routine ESOP allotment disclosure with no material impact on existing shareholders. The grant is a small number of shares (50,000) relative to the company's overall size, so dilution impact is negligible. Positive signal for employee retention and alignment with shareholders.